Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Oncogene

Volumn 27, Issue 25, 2008, Pages 3635-3640

  Kwei, K A ^a   Kim, Y H ^a   Girard, L ^b   Kao, J ^a   Pacyna Gengelbach, M ^c   Salari, K ^d   Lee, J ^a   Choi, Y L ^a,e   Sato, M ^b   Wang, P ^f   Hernandez Boussard, T ^d   Gazdar, A F ^b   Petersen, I ^c   Minna, J D ^b   Pollack, J R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d STANFORD UNIVERSITY   (United States)

^e Sungkyunkwan University   (South Korea)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Genomic profiling; Lineage specific oncogene; Lung cancer; NKX2 1; TITF1; TTF 1

Indexed keywords

RNA; SMALL INTERFERING RNA; THYROID TRANSCRIPTION FACTOR 1;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME 14Q; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCUS; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG DEVELOPMENT; LUNG FUNCTION; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION;

APOPTOSIS; CELL LINE, TUMOR; CELL LINEAGE; CHROMOSOME MAPPING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 44449178497     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1211012     Document Type: Article

References (31)

1. Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA et al. (2005). Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia 7: 556-562.
2. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, Lonning PE et al. (2006). Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45: 1033-1040.
3. Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y et al. (2006). 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3: 199-204.
4. Bohinski RJ, Di Lauro R, Whitsett JA. (1994). The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 14: 5671-5681.
5. Garraway LA, Sellers WR. (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6: 593-602.
6. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122.
7. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M et al. (2007). Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39: 655-660.
8. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J et al. (2006). Position-specific chemical modification of siRNAs reduces 'off-target' transcript silencing. RNA 12: 1197-1205.
9. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. (2007). Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
10. Kao J, Pollack JR. (2006). RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes. Genes Chromosomes Cancer 45: 761-769.
11. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B et al. (2007). Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci USA 104: 16663-16668.
12. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. (2002). The human genome browser at UCSC. Genome Res 12: 996-1006.
13. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM et al. (1996). The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10: 60-69.
14. Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P et al. (2007). Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 67: 8504-8510.
15. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K et al. (2004). Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 101: 811-816.
16. Lechner JF, Fugaro JM, Wong Y, Pass HI, Harris CC, Belinsky SA. (2001). Perspective: cell differentiation theory may advance early detection of and therapy for lung cancer. Radiat Res 155: 235-238.
17. Miccadei S, De Leo R, Zammarchi E, Natali PG, Civitareale D. (2002). The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/enhancer interplay. Mol Endocrinol 16: 837-846.
18. Minoo P, Su G, Drum H, Bringas P, Kimura S. (1999). Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dev Biol 209: 60-71.
19. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF et al. (1999). Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23: 41-46.
20. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE et al. (2002). Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99: 12963-12968.
21. Puglisi F, Barbone F, Damante G, Bruckbauer M, Di Lauro V, Beltrami CA et al. (1999). Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 12: 318-324.
22. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J et al. (2004). Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034.
23. Sato M, Shames DS, Gazdar AF, Minna JD. (2007). A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2: 327-343.
24. Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J et al. (2003). Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum Pathol 34: 597-604.
25. Tanaka H, Yanagisawa K, Shinjo K, Taguchi A, Maeno K, Tomida S et al. (2007). Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 67: 6007-6011.
26. Tian J, Mahmood R, Hnasko R, Locker J. (2006). Loss of Nkx2.8 deregulates progenitor cells in the large airways and leads to dysplasia. Cancer Res 66: 10399-10407.
27. Tibshirani R, Wang P. (2008). Spatial smoothing and hot spot detection for CGH data using the fused lasso. Biostatistics 9: 18-29.
28. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. (2004). Pathology & Genetics: Tumours of the lung, pleura, thymus and heart. (World Health Organization Classification of Tumours). IARC Press: Lyon.
29. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C et al. (1995). In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401-406.
30. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. (2007). Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
31. Yatabe Y, Mitsudomi T, Takahashi T. (2002). TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 26: 767-773.